Skip to main content
Clinical Trials/ACTRN12624000745549
ACTRN12624000745549
Not yet recruiting
未知

Investigating the effect of a mHealth assisted allied health opioid tapering intervention on daily opioid use for chronic pain: the MOTION-Pilot randomised controlled trial

The University of Queensland0 sites50 target enrollmentJune 17, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
The University of Queensland
Enrollment
50
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 17, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients will be eligible to participate in the trial if they: i) have a pain duration equal to or greater than 3 months, ii) are aged 18 \- 80 years, iii) have non\-malignant pain, iv) are prescribed opioids, and v) are open to engaging with allied health staff to discuss their pain medications.

Exclusion Criteria

  • Individuals will be excluded if they: i) cannot communicate in English, ii) have a significant intellectual or cognitive impairment, iii) have active psychosocial issues including suicidal intent, or psychosis, iv) intravenous drug use, v) are currently using any implanted device for pain control (e.g., intrathecal pump, spinal cord stimulator, peripheral nerve stimulator), vi) have had surgery within the previous month or have surgery planned during the next 6 months and vii) evidence of recent aberrant drug\-related behaviours (i.e. stealing or borrowing drugs from others, altering mode of administration of drug delivery and aggressive complaints about the need for more medication)

Outcomes

Primary Outcomes

Not specified

Similar Trials